Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Annual Meeting

Why would the reverse not apply to all shares equally, issued or not? It seems that they are all part of the same pot.

On a different line of thought popped over to see what EDIG is up to the other days since it has been mentioned here in the past as a similar type investment. Looks like they are having some success in licensing. Hope the same comes true here at some point. If it does it will have been a long time coming...

Still wishing GLTA

Share
New Message
Please login to post a reply